Most people think about longevity wrong. They focus on lifespan — the number of years lived — when the real goal is healthspan: the number of years lived well. The distinction matters enormously. Adding a decade of decline to the end of your life is not the same as adding a decade of vitality to the middle of it.

The VanguardBIO Longevity Protocol was built around this distinction. Six compounds, each targeting a specific mechanism of biological aging, working together to slow cellular deterioration, restore energy production, and protect the systems that keep you functioning at a high level.

This is a complete guide to how it works, what each compound does, and what you can realistically expect.

Before examining the compounds, it helps to understand what aging actually is at the cellular level. Biological aging is not a single process — it is the accumulation of several interconnected failures:

Oxidative stress accumulation. Free radicals — unstable molecules produced by normal metabolism — damage DNA, proteins, and cell membranes over time. Your body's antioxidant systems neutralize them, but those systems weaken with age. The result is accelerating cellular damage.

Mitochondrial decline. Mitochondria are the energy-producing organelles in every cell. As you age, mitochondrial function degrades. You produce less ATP, your cells become less efficient, and the downstream effects — fatigue, cognitive decline, slower recovery — compound over time.

Collagen and extracellular matrix breakdown. Collagen is the structural protein that holds skin, joints, tendons, and connective tissue together. Production slows dramatically after 25 and continues declining. The visible and functional consequences are well-documented.

Growth hormone axis decline. HGH and IGF-1 levels fall steadily after your mid-twenties. This drives changes in body composition — more fat, less lean muscle — and impairs the cellular repair processes that HGH governs.

Epigenetic dysregulation. Gene expression patterns shift with age in ways that accelerate deterioration. Some of these shifts are reversible with the right interventions.

The Longevity Protocol addresses all five of these mechanisms.

Glutathione is the body's primary endogenous antioxidant. Every cell produces it, and it is the first line of defense against oxidative damage. The problem: glutathione levels decline by roughly 1% per year after age 20. By 60, most people are operating at 40–50% of their youthful glutathione capacity.

Supplementing glutathione directly — particularly in reduced form via subcutaneous delivery — bypasses the digestive degradation that makes oral supplementation largely ineffective. The result is a measurable increase in cellular antioxidant capacity, reduced oxidative stress markers, and protection of the mitochondria from free radical damage.

Glutathione also plays a central role in detoxification, immune function, and the recycling of other antioxidants including vitamins C and E. It is foundational to the entire protocol.

GHK-Cu (copper peptide) is one of the most extensively studied anti-aging compounds in the literature. It is a naturally occurring tripeptide that declines sharply with age — plasma levels in a 60-year-old are roughly one-third of those in a 20-year-old.

GHK-Cu works through multiple mechanisms. It activates genes involved in collagen and elastin synthesis, stimulates wound healing, modulates inflammation, and has been shown to reset gene expression patterns in aged cells toward a younger profile. A landmark study by Pickart and Margolina identified over 4,000 human genes regulated by GHK-Cu — roughly one-third of the genome.

The practical effects include improved skin structure and elasticity, accelerated tissue repair, and anti-inflammatory action throughout the body. For anyone concerned with the visible and structural consequences of aging, GHK-Cu is among the most evidence-backed interventions available.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell. It is essential for mitochondrial energy production, DNA repair, and the activation of sirtuins — a family of proteins often called "longevity genes" for their role in regulating cellular health and lifespan.

NAD+ levels decline by approximately 50% between ages 40 and 60. This decline is not incidental — it is one of the primary drivers of the mitochondrial dysfunction, cognitive decline, and metabolic deterioration associated with aging.

Direct NAD+ supplementation via subcutaneous delivery achieves plasma levels that oral precursors like NMN and NR cannot reliably match. The effects are measurable: improved mitochondrial function, enhanced DNA repair capacity, activated sirtuin pathways, and — for most subscribers — a noticeable improvement in energy, mental clarity, and exercise tolerance within the first four to six weeks.

TB-500 (Thymosin Beta-4) is a peptide with potent regenerative properties. In the context of the Longevity Protocol, its primary role is systemic tissue maintenance — repairing the accumulated micro-damage in connective tissue, joints, and muscle that accumulates over decades of use.

TB-500 promotes angiogenesis (new blood vessel formation), reduces inflammation, and accelerates the repair of damaged tissue. It is particularly effective for chronic joint issues, tendon degradation, and the kind of low-grade connective tissue damage that most people attribute simply to "getting older."

The anti-fibrotic properties of TB-500 are also relevant to longevity: fibrosis — the replacement of functional tissue with scar tissue — is a hallmark of aging in multiple organ systems. TB-500 actively counteracts this process.

Melanotan II is an MC1R and MC4R agonist with two distinct longevity-relevant effects. First, it stimulates melanin production, providing endogenous photoprotection against UV-induced DNA damage — one of the primary drivers of skin aging and a significant contributor to oxidative stress systemically.

Second, through MC4R agonism, Melanotan II modulates appetite and metabolic rate. The resulting reduction in caloric intake and improvement in body composition has downstream effects on insulin sensitivity, inflammatory markers, and cardiovascular risk factors — all of which are central to healthspan.

The combination of UV protection and metabolic support makes Melanotan II a uniquely dual-purpose compound in the longevity context.

Human Growth Hormone governs cellular repair, body composition, and metabolic function. Its decline after the mid-twenties is one of the most consequential hormonal shifts in the aging process — driving the loss of lean muscle, accumulation of visceral fat, and impaired recovery that most people experience as the defining features of middle age.

Low-dose HGH supplementation in the Longevity Protocol is calibrated to restore levels toward the physiological range of a healthy 30-year-old, not to the supraphysiological levels associated with performance enhancement. The goal is restoration, not augmentation. The effects — improved body composition, enhanced recovery, better sleep quality, and improved skin structure — are well-documented in the clinical literature on adult growth hormone deficiency.

The power of the Longevity Protocol is not in any single compound — it is in the synergy between them.

Glutathione and NAD+ address the two primary drivers of cellular aging: oxidative stress and mitochondrial decline. GHK-Cu and HGH work together on tissue structure and repair — GHK-Cu at the extracellular matrix level, HGH at the systemic hormonal level. TB-500 handles the accumulated physical damage that compounds over decades. Melanotan II protects against ongoing UV damage while supporting the metabolic environment that makes everything else work better.

Each compound reinforces the others. NAD+ supports the mitochondrial function that Glutathione protects. HGH and TB-500 both promote tissue repair through complementary mechanisms. GHK-Cu's gene-regulatory effects amplify the collagen synthesis that HGH stimulates.

Weeks 1–4: Most subscribers notice improved energy and sleep quality first. NAD+ effects on mitochondrial function are often the earliest and most pronounced. Some notice reduced joint discomfort from TB-500 within the first two to three weeks.

Weeks 4–8: Skin texture and elasticity improvements become visible — primarily from GHK-Cu and HGH. Body composition begins to shift. Cognitive clarity and sustained energy are consistently reported in this window.

Weeks 8–12: The cumulative effects of oxidative stress reduction (Glutathione), collagen synthesis (GHK-Cu + HGH), and systemic tissue repair (TB-500) become measurable in biomarkers. Subscribers who track labs typically see improvements in inflammatory markers, IGF-1, and erythrocyte glutathione levels.

Beyond 12 weeks: The protocol's effects compound. Biological aging is a slow process; reversing its markers requires consistent intervention over time. Most subscribers report that the protocol's effects continue to build through the first six months.

The Longevity Protocol is most effective when paired with objective measurement. The biomarkers worth tracking before starting and at 90-day intervals include:

• 8-OHdG (oxidative DNA damage marker)
• Erythrocyte glutathione (cellular antioxidant status)
• IGF-1 (growth hormone axis activity)
• hs-CRP (systemic inflammation)
• HRV (heart rate variability — a proxy for autonomic and mitochondrial health)
• Fasting insulin and glucose (metabolic health)

These are not vanity metrics. They are the upstream indicators that determine how you will feel and function at 60, 70, and beyond.

The Longevity Protocol is not a supplement stack. It is a systematic intervention in the biology of aging — six compounds targeting the specific mechanisms that drive cellular deterioration, working together in a way that no single compound can replicate.

The science is rigorous. The compounds are well-characterized. The delivery method — subcutaneous, compounding-pharmacy quality — ensures bioavailability that oral alternatives cannot match.

If you are serious about healthspan, this is where the evidence points.